NewEdge Advisors LLC Has $1.39 Million Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• NewEdge Advisors increased its Sabra Healthcare REIT position by 261.2% in the second quarter, bringing its holdings to 71,128 shares worth approximately $1.39 million. Institutional investors collectively own 99.4% of SBRA.
• Analysts maintain a generally positive outlook, with a “Moderate Buy” consensus rating and an average price target of $22.23. Seven analysts rate the stock a Buy and seven rate it a Hold.
• Sabra reported quarterly revenue of $230.1 million, up 24.7% year over year, but missed the EPS consensus estimate. The company paid a quarterly dividend of $0.30, implying a 6.1% annualized yield, while its CEO sold 200,000 shares under a pre-arranged trading plan.

NewEdge Advisors LLC lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 261.2% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 71,128 shares of the real estate investment trust's stock after purchasing an additional 51,435 shares during the quarter. NewEdge Advisors LLC's holdings in Sabra Healthcare REIT were worth $1,388,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of SBRA. Principal Financial Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust's stock worth $481,755,000 after acquiring an additional 98,770 shares during the period. Geode Capital Management LLC boosted its stake in Sabra Healthcare REIT by 2.9% in the 4th quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust's stock worth $132,949,000 after purchasing an additional 198,118 shares during the period. Lasalle Investment Management Securities LLC increased its holdings in Sabra Healthcare REIT by 8.2% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust's stock worth $73,547,000 after purchasing an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Sabra Healthcare REIT by 7.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust's stock worth $71,640,000 after purchasing an additional 269,793 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Sabra Healthcare REIT by 6.8% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust's stock valued at $61,701,000 after purchasing an additional 203,226 shares during the period. 99.40% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Wall Street Zen upgraded Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. UBS Group set a $25.00 target price on Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Robert W. Baird upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a "neutral" rating in a research report on Monday, August 31st. Finally, Barclays upped their price target on Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, August 31st. Seven research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $22.23.

Insider Buying and Selling at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the business's stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. The trade was a 10.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company's stock.

Sabra Healthcare REIT Price Performance

NASDAQ:SBRA opened at $19.74 on Monday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07. The stock's 50-day simple moving average is $20.73 and its 200 day simple moving average is $20.19. The company has a market cap of $5.04 billion, a P/E ratio of 75.93, a P/E/G ratio of 1.50 and a beta of 0.65. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business's revenue for the quarter was up 24.7% on a year-over-year basis. During the same period last year, the company posted $0.38 earnings per share. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. The ex-dividend date of this dividend was Friday, August 14th. Sabra Healthcare REIT's dividend payout ratio is presently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.